Polynucleotide capture assay employing in vitro amplification

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5200314
SERIAL NO

07497938

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An analyte polynucleotide strand having an analyte sequence is detected within a sample containing polynucleotides by contacting the analyte polynucleotide with a capture probe under hybridization conditions, where the capture probe has a first binding partner specific for a solid-phase second binding partner. The resulting duplex is then immobilized by specific binding between the binding partners, and non-bound polynucleotides are separated from the bound species. The analyte polynucleotide is optionally displaced from the solid phase, then amplified by PCR. The PCR primers each have a polynucleotide region capable of hybridizing to a region of the analyte polynucleotide, and at least one of the primers further has an additional binding partner capable of binding a solid-phase binding partner. The amplified product is then separated from the reaction mixture by specific binding between the binding partners, and the amplified product is detected.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SIEMENS HEALTHCARE DIAGNOSTICS INC511 BENEDICT AVE TARRYTOWN NY 10591

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Urdea, Michael Alamo, CA 1 239

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation